Somatic mutation of targeted sequencing identifies risk stratification in advanced ovarian clear cell carcinoma. Wan S, Gao Y, Wu S, Wang H, et al. Gynecol Oncol 2024;191:56-66.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wan S, Gao Y, Wu S, Wang H, et al. Somatic mutation of targeted sequencing identifies risk stratification in advanced ovarian clear cell carcinoma. Gynecol Oncol 2024;191:56-66.
PMID: 39342920